{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2023-03-31", "title": "Protocol Controlled Terminology Package 53 Effective 2023-03-31", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/protocolct-2022-12-16/codelists/C177907", "title": "CDISC Protocol Ingredient Type Value Set Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C177907", "title": "Version-agnostic anchor resource for codelist C177907", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2023-03-31/codelists/C177907", "title": "CDISC Protocol Ingredient Type Value Set Terminology", "type": "Code List"}}, "conceptId": "C177907", "definition": "The terminology relevant to the identification of the kind of ingredient.", "name": "Ingredient Type Value Set Terminology", "preferredTerm": "CDISC Protocol Ingredient Type Value Set Terminology", "submissionValue": "Ingredient Type Value Set Terminology", "synonyms": ["Ingredient Type Value Set Terminology"], "terms": [{"conceptId": "C82533", "definition": "Any component of a drug product intended to exert pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body of humans or other animals. (After 21 CFR 210.3(b)(7))", "preferredTerm": "Active Ingredient", "submissionValue": "Active Ingredient"}, {"conceptId": "C42637", "definition": "Any component of a study product other than an active ingredient. (After FDA 21 CFR 210.3(b)(8))", "preferredTerm": "Pharmaceutical Excipient", "submissionValue": "Inactive Ingredient", "synonyms": ["Inert Ingredient"]}]}